Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 44th Annual J.P.

Reported 12-month overall survival (OS) in Phase 2a clinical trial nearly double the benchmark from pivotal study of standard ...

The Ketchikan City Council during a regular meeting Tuesday approved ordinances setting 8.0% water and sewer rate increases in first readings.

FDA assigned PDUFA target action date of July 7, 2026. If approved, atacicept would be the first B cell modulator targeting both BAFF and APRIL for IgAN. Atacicept received FDA Breakthrough Therapy ...

The Scandinavian winter months are a challenging period. Long, dark nights and days with hardly any sunshine allow melancholy ...